Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Venkateshwarla Rama Raju, Rukmini Kandadai Mridula & Rupam Borgohain. (2022) Effect of Microelectrode Recording in Accurate Targeting STN with High Frequency DBS in Parkinson Disease. IETE Journal of Research 68:1, pages 136-149.
Read now
Read now
Garima Srivastava, Kavita Singh, Manindra Nath Tiwari & Mahendra Pratap Singh. (2010) Proteomics in Parkinson’s disease: current trends, translational snags and future possibilities. Expert Review of Proteomics 7:1, pages 127-139.
Read now
Read now
Uwe Walter. (2009) Transcranial brain sonography findings in Parkinson’s disease: implications for pathogenesis, early diagnosis and therapy. Expert Review of Neurotherapeutics 9:6, pages 835-846.
Read now
Read now
Articles from other publishers (24)
Elena A. Katunina, Victor Blokhin, Marina R. Nodel, Ekaterina N. Pavlova, Alexander L. Kalinkin, Valerian G. Kucheryanu, Leyla Alekperova, Marianna V. Selikhova, Mikhail Yu. Martynov & Michael V. Ugrumov. (2023) Searching for Biomarkers in the Blood of Patients at Risk of Developing Parkinson’s Disease at the Prodromal Stage. International Journal of Molecular Sciences 24:3, pages 1842.
Crossref
Crossref
V Rama Raju. (2022) Analysis of MER with subthalamic nucleus stimulations with deep brain stimulation. IP Indian Journal of Neurosciences 8:1, pages 64-68.
Crossref
Crossref
Julia Das, Lisa Graham, Rosie Morris, Gill Barry, Alan Godfrey, Richard Walker & Samuel Stuart. 2022. Eye Tracking. Eye Tracking
185
205
.
E. I. Gusev, E. A. Katunina, M. Yu. Martinov, V. E. Blokhin, A. L. Kalinkin, A. V. Alesenko, M. R. Nodel, E. A. Malykhina, N. V. Titova, D. A. Katunin, M. A. Shupik, U. A. Gutner, O. A. Maloshitskaya, S. A. Sokolov, V. G. Kucheryanu, E. N. Pavlova & M. V. Ugrumov. (2021) Development of Early Diagnosis of Parkinson’s Disease Using Premotor Symptoms and Blood Changes as Biomarkers. Neuroscience and Behavioral Physiology 51:8, pages 1050-1058.
Crossref
Crossref
Frédérique Depierreux, Eric Parmentier, Laurane Mackels, Katherine Baquero, Christian Degueldre, Evelyne Balteau, Eric Salmon, Christophe Phillips, Mohamed Ali Bahri, Pierre Maquet & Gaëtan Garraux. (2021) Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI. npj Parkinson's Disease 7:1.
Crossref
Crossref
Venkateshwarla Rama Raju. (2021) Implantation of microchips into the subthalamic nucleus neurons of Parkinson‘s disease and movement disorders. IP Indian Journal of Neurosciences 7:1, pages 83-88.
Crossref
Crossref
E.I. Gusev, V.E. Blokhin, S.A. Vartanov, M.Yu. Martynov, E.A. Katunina, A.V. Alesenko, I.A. Denisova, E.N. Pavlova, V.M. Polterovich, V.G. Kucheryanu, M.A. Shupik, M.R. Nodel, A.L. Kalinkin, S.A. Sokolov, T.V. Chubarova, M.V. Shakleina, T.S. Pronina & M.V. Ugryumov. (2021) Development of early diagnosis of Parkinson’s disease and comprehensive economic analysis of the effect of its implementation. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:1, pages 9.
Crossref
Crossref
Della G.T. Parambi. (2020) Treatment of Parkinson’s Disease by MAO-B Inhibitors, New Therapies and Future Challenges - A Mini-Review. Combinatorial Chemistry & High Throughput Screening 23:9, pages 847-861.
Crossref
Crossref
E.I. Gusev, E.A. Katunina, M.Yu. Martinov, V.E. Blokhin, A.L. Kalinkin, A.V. Alesenko, M.R. Nodel, E.A. Malykhina, N.V. Titova, D.A. Katunin, M.A. Shupik, U.A. Gutner, O.A. Maloshitskaya, S.A. Sokolov, V.G. Kucheryanu, E.N. Pavlova & M.V. Ugrumov. (2020) Development of early diagnosis of Parkinson’s disease based on the search for biomarkers such as premotor symptoms and changes in blood. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 120:12, pages 7.
Crossref
Crossref
Samuel Stuart, Rachael A. Lawson, Alison J. Yarnall, Jeremy Nell, Lisa Alcock, Gordon W. Duncan, Tien K. Khoo, Roger A. Barker, Lynn Rochester & David J. Burn. (2019) Pro‐Saccades Predict Cognitive Decline in Parkinson's Disease: ICICLE‐PD. Movement Disorders 34:11, pages 1690-1698.
Crossref
Crossref
John Prince, Fernando Andreotti & Maarten De Vos. (2019) Multi-Source Ensemble Learning for the Remote Prediction of Parkinson's Disease in the Presence of Source-Wise Missing Data. IEEE Transactions on Biomedical Engineering 66:5, pages 1402-1411.
Crossref
Crossref
Sumit Sarkar, James Raymick & Syed Imam. (2016) Neuroprotective and Therapeutic Strategies against Parkinson’s Disease: Recent Perspectives. International Journal of Molecular Sciences 17:6, pages 904.
Crossref
Crossref
Martin J. McKeownGuerry M. Peavy. (2015) Biomarkers in Parkinson disease. Neurology 84:24, pages 2392-2393.
Crossref
Crossref
Natalie E. Allen, Niamh Moloney, Vanessa van Vliet & Colleen G. Canning. (2015) The Rationale for Exercise in the Management of Pain in Parkinson’s Disease. Journal of Parkinson's Disease 5:2, pages 229-239.
Crossref
Crossref
Peter A. LeWitt, Jia Li, Mei Lu, Thomas G. Beach, Charles H. Adler & Lining Guo. (2013) 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis. Movement Disorders 28:12, pages 1653-1660.
Crossref
Crossref
Peter A. LeWitt, Bertrand R. Huber & Jing Zhang. 2013. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future. Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future
161
184
.
Yoland Smith, Thomas Wichmann, Stewart A Factor & Mahlon R DeLong. (2011) Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa. Neuropsychopharmacology 37:1, pages 213-246.
Crossref
Crossref
Wang Zhan, Gail A. Kang, Graham A. Glass, Yu Zhang, Cheryl Shirley, Rachel Millin, Katherine L. Possin, Marzieh Nezamzadeh, Michael W. Weiner, William J. MarksJr.Jr. & Norbert Schuff. (2012) Regional alterations of brain microstructure in Parkinson's disease using diffusion tensor imaging. Movement Disorders 27:1, pages 90-97.
Crossref
Crossref
S. M. Rissanen, M. Kankaanpaä, M. P. Tarvainen, V. Novak, P. Novak, Kun Hu, B. Manor, O. Airaksinen & P. A. Karjalainen. (2011) Analysis of EMG and Acceleration Signals for Quantifying the Effects of Deep Brain Stimulation in Parkinson’s Disease. IEEE Transactions on Biomedical Engineering 58:9, pages 2545-2553.
Crossref
Crossref
S. M. Rissanen, M. Kankaanpaa, M. P. Tarvainen, J. Nuutinen, O. Airaksinen & P. A. Karjalainen. (2011) EMG and acceleration signal analysis for quantifying the effects of medication in Parkinson's disease. EMG and acceleration signal analysis for quantifying the effects of medication in Parkinson's disease.
Peter LeWitt, Lonni Schultz, Peggy Auinger & Mei Lu. (2011) CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease. Brain Research 1408, pages 88-97.
Crossref
Crossref
Salvatore Galati & Giuseppe Di Giovanni. (2010) Neuroprotection in Parkinson's Disease: a Realistic Goal?. CNS Neuroscience & Therapeutics 16:6, pages 327-329.
Crossref
Crossref
Corina Kohler, Ramin Radpour, Zeinab Barekati, Reza Asadollahi, Johannes Bitzer, Edward Wight, Nicole Bürki, Claude Diesch, Wolfgang Holzgreve & Xiao Yan Zhong. (2009) Levels of plasma circulating cell free nuclear and mitochondrial DNA as potential biomarkers for breast tumors. Molecular Cancer 8:1.
Crossref
Crossref
Gráinne C. O’Keeffe, Andrew W. Michell & Roger A. Barker. (2009) Biomarkers in Huntington's and Parkinson's Disease. Annals of the New York Academy of Sciences 1180:1, pages 97-110.
Crossref
Crossref